Baird maintains value goal on Instil Bio inventory, stays upbeat By Investing.com
On Tuesday, Baird reaffirmed its constructive stance on shares of Instil Bio…
Barinthus Bio will get Purchase inventory ranking on trial progress By Investing.com
On Wednesday, H.C. Wainwright maintained a optimistic stance on Barinthus Biotherapeutics (NASDAQ:BRNS)…
INmune Bio stories progress in prostate most cancers trial By Investing.com
BOCA RATON, Fla. - INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology…
H.C. Wainwright retains Purchase on Gossamer Bio, highlights collaboration with Chiesi Group for seralutinib By Investing.com
On Friday, H.C. Wainwright maintained a constructive stance on Gossamer Bio Inc…
INmune Bio shares get sector outperform ranking on AD drug potential By Investing.com
On Thursday, Scotiabank initiated protection on shares of INmune Bio Inc. (NASDAQ:INMB)…
